![EBCTCG Analysis Identifies Recurrence Risk by Tumor Subgroup in Estrogen Receptor–Positive Breast Cancer - The ASCO Post EBCTCG Analysis Identifies Recurrence Risk by Tumor Subgroup in Estrogen Receptor–Positive Breast Cancer - The ASCO Post](https://ascopost.com/media/14002242/71304_table-1.jpg)
EBCTCG Analysis Identifies Recurrence Risk by Tumor Subgroup in Estrogen Receptor–Positive Breast Cancer - The ASCO Post
![Radiotherapy for older women (ROW)”: A risk calculator for women with early-stage breast cancer - ScienceDirect Radiotherapy for older women (ROW)”: A risk calculator for women with early-stage breast cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1879406819303534-gr3.jpg)
Radiotherapy for older women (ROW)”: A risk calculator for women with early-stage breast cancer - ScienceDirect
![Late recurrence of breast cancer is associated with pro-cancerous immune microenvironment in the primary tumor | Scientific Reports Late recurrence of breast cancer is associated with pro-cancerous immune microenvironment in the primary tumor | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-53482-x/MediaObjects/41598_2019_53482_Fig1_HTML.png)
Late recurrence of breast cancer is associated with pro-cancerous immune microenvironment in the primary tumor | Scientific Reports
![Cancers | Free Full-Text | Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review Cancers | Free Full-Text | Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review](https://www.mdpi.com/cancers/cancers-14-01898/article_deploy/html/images/cancers-14-01898-g001.png)
Cancers | Free Full-Text | Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review
Prognostic value of the Residual Cancer Burden index according to breast cancer subtype: Validation on a cohort of BC patients treated by neoadjuvant chemotherapy | PLOS ONE
![A new clinical-genomic model to predict 10-year recurrence risk in primary operable breast cancer patients | Scientific Reports A new clinical-genomic model to predict 10-year recurrence risk in primary operable breast cancer patients | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-61535-9/MediaObjects/41598_2020_61535_Fig1_HTML.png)